Objectives
The use of nonsteroidal anti‐inflammatory drugs (NSAIDs) in heart failure patients is known to be associated with a wide range of adverse events, including an increased risk of cardiovascular complications. This study aimed to evaluate the effectiveness of an education programme in improving the knowledge about the safety of NSAID use among the hospitalized heart failure patients.
Method
This was a single‐arm, quasi‐experimental study. It was undertaken in a regional referral centre in Perak State, Malaysia. Each recruited patient received an educational leaflet and a 10‐min counselling intervention by a clinical pharmacist. A 5‐item questionnaire was used to assess their knowledge before and after the intervention. Each correct answer was awarded with 1 point, and a patient with a total score of 3 points or above was considered having adequate knowledge.
Key findings
A total of 31 patients received the intervention and completed the assessment. They were mainly female (61%), with a median age of 68 (interquartile range (IQR) = 22) years. Of all the patients, four (13.3%) reported a long‐term use of NSAIDs, while only one (3.2%) reported the use of NSAIDs in 1 week before the hospitalization. The postintervention score (median = 3; IQR = 2) was shown to be significantly higher than the preintervention score (median = 1; IQR = 2; P = < 0.001). Additionally, the majority of the patients (86.7%) found the education programme was useful to avoid unnecessary NSAID use in the future.
Conclusions
Our findings suggest that the pharmacist‐initiated education programme is useful and could be used as a long‐term strategy to improve the knowledge about the safety of NSAID use in heart failure patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.